Ferid Murad
8Patents
4h-index
13Co-inventors
54Inventor score
Filing activity: Feb 16, 1983 → Aug 4, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4474892A | Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same | Emerging Cross-Sectional Technologies | 49 | Expired |
| US5380945A | Guanidino compounds as regulators of nitric oxide synthase | Chemistry; Metallurgy | 19 | Expired |
| US8980331B2 | Extended production of nitric oxide from microencapsulated chemical reactants | Human Necessities | 15 | Active |
| US5478946A | Guanidino compounds as regulators of nitric oxide synthase | Chemistry; Metallurgy | 10 | Expired |
| US9445996B2 | Extended production of nitric oxide from a microencapsulated nitrite salt and an aqueous acidified gel | Human Necessities | 4 | Active |
| US7223606B2 | Methods of detecting nitrotyrosine and aminotyrosine residues of peptides and proteins | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7214519B2 | Screening method for identifying heme independent modulators of soluble guanylyl cyclase (sGC) activity using αβCys105 mutant sGC | Human Necessities | 0 | Expired |
| US11541094B2 | Formulations for treating metabolic syndrome and increasing energy levels | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.